Cytosystems Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $671K
Latest Deal Amount
  • Investors
  • 6

Cytosystems General Information

Description

Developer of diagnostic technologies designed to detect varieties of cancer. The company's technologies use non-invasive cancer diagnostic and stratification process, with an emphasis on a whole-cell approach for improved clinical decision-making, enabling doctors to identify and treat cancer in the early stages.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Decision/Risk Analysis
Primary Office
  • Craigiebuckler
  • Aberdeen AB15 8QH
  • Scotland, United Kingdom
+44 01224 000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 19-Jul-2016 $671K 00.000 Completed Generating Revenue
6. Grant 01-Jun-2015 00.000 00.000 Completed Generating Revenue
5. Early Stage VC 23-Jul-2012 00000 00.000 00.000 Completed
4. Early Stage VC 19-Sep-2011 00000 00.000 00.00 Completed
3. Early Stage VC 06-Oct-2009 00.000 00.000 00.000 Completed
2. Early Stage VC 31-Jan-2007 Completed Startup
1. Early Stage VC 25-Nov-2006 Completed Startup
To view Cytosystems’s complete valuation and funding history, request access »

Cytosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Pref 000 00.000000 000.00 000.00 00 000.00 0.000
D Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
D Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
E Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
D Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
C Ordinary 000 00.000000 0000.00 0000.00 00 0000.00 0.000
B Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
B Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
A Ordinary 2,046 $0.015585 $57.12 $57.12 1x $57.12 2.3%
A Ordinary 3,238 $0.015585 $43.31 $43.31 1x $43.31 3.64%
To view Cytosystems’s complete cap table history, request access »

Cytosystems Executive Team (3)

Name Title Board Seat Contact Info
Richard Berry Board Member & Chief Executive Officer
David Galloway Ph.D Founder
To view Cytosystems’s complete executive team members history, request access »

Cytosystems Board Members (3)

Name Representing Role Since
Nadir Mahjoub Self Board Member 000 0000
Richard Berry Cytosystems Board Member & Chief Executive Officer 000 0000
To view Cytosystems’s complete board members history, request access »

Cytosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytosystems Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Aurora Private Equity Angel Group Minority 000 0000 000000 0
Cancer Research UK Venture Capital Minority 000 0000 000000 0
Scottish Enterprise Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »